These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12055700)

  • 21. Prevalence of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family medicine framework--results of LIPIDOGRAM 2005--a nationwide epidemiological study. Dyslipidemia in Poland--ineffective treatment.
    Konduracka E; Jóźwiak J; Mastej M; Lukas W; Tykarski A; Szczepaniak-Chicheł L; Piwowarska W
    Przegl Lek; 2008; 65(12):834-7. PubMed ID: 19441674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acid profile, fibre content and high magnesium density of nuts may protect against risk of coronary heart disease events.
    Durlach J; Rayssiguier Y
    Magnes Res; 1993 Jun; 6(2):191-2. PubMed ID: 8274365
    [No Abstract]   [Full Text] [Related]  

  • 23. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human genetics and prevention of coronary heart disease.
    Bull Pan Am Health Organ; 1984; 18(4):406-7. PubMed ID: 6525486
    [No Abstract]   [Full Text] [Related]  

  • 25. [The role of physical activity in the prevention and treatment of ischemic heart disease].
    Denolin H
    Ann Cardiol Angeiol (Paris); 1981; 30(2):103-8. PubMed ID: 7259041
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of gender, age and motives underlying food choice on perceived healthiness and willingness to try functional foods.
    Ares G; Gámbaro A
    Appetite; 2007 Jul; 49(1):148-58. PubMed ID: 17335938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in diet quality for coronary heart disease prevention between 1980-1982 and 2000-2002: The Minnesota Heart Survey.
    Lee S; Harnack L; Jacobs DR; Steffen LM; Luepker RV; Arnett DK
    J Am Diet Assoc; 2007 Feb; 107(2):213-22. PubMed ID: 17258957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-year evaluation of electronic medical record flag alerts for patients warranting secondary prevention of coronary heart disease.
    Whitley HP; Fermo JD; Chumney EC
    Pharmacotherapy; 2006 May; 26(5):682-8. PubMed ID: 16637797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impressions of functional food consumers.
    Saher M; Arvola A; Lindeman M; Lähteenmäki L
    Appetite; 2004 Feb; 42(1):79-89. PubMed ID: 15036786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and prevention of coronary heart disease.
    Ghosh BN
    Indian Pract; 1965 Sep; 18(9):671-5. PubMed ID: 5841518
    [No Abstract]   [Full Text] [Related]  

  • 31. The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project.
    Niu S; Zhao D; Zhu J; Liu J; Liu Q; Liu J; Wang W; Smith SC;
    Am Heart J; 2009 Apr; 157(4):709-15.e1. PubMed ID: 19332200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking status, sports participation and mortality from coronary heart disease.
    Noda H; Iso H; Toyoshima H; Date C; Yamamoto A; Kikuchi S; Koizumi A; Kondo T; Watanabe Y; Wada Y; Inaba Y; Tamakoshi A;
    Heart; 2008 Apr; 94(4):471-5. PubMed ID: 17916664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
    Fox DJ; Kibiro M; Eichhöfer J; Curzen NP
    Postgrad Med J; 2005 Jun; 81(956):401-3. PubMed ID: 15937208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single mathematical model predicts physicians' recommendations and postmenopausal women's decisions to participate in a clinical trial to prevent breast cancer or coronary heart disease.
    Veit CT
    Med Decis Making; 2004; 24(4):330-50. PubMed ID: 15271272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approach.
    Martikainen JA; Ottelin AM; Kiviniemi V; Gylling H
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):265-72. PubMed ID: 17446806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative.
    Barnhart J; Lewis V; Houghton JL; Charney P
    Womens Health Issues; 2007; 17(2):93-100. PubMed ID: 17403466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiologic variations in the control of coronary heart disease].
    Colaković B
    Med Arh; 1980; 34(1):13-7. PubMed ID: 7464260
    [No Abstract]   [Full Text] [Related]  

  • 39. Mediterranean diet and survival among patients with coronary heart disease in Greece.
    Trichopoulou A; Bamia C; Trichopoulos D
    Arch Intern Med; 2005 Apr; 165(8):929-35. PubMed ID: 15851646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring the impact of HIV/AIDS, heart disease and malignant neoplasms on life expectancy in the USA from 1987 to 2000.
    Lai DJ; Tarwater PM; Hardy RJ
    Public Health; 2006 Jun; 120(6):486-92. PubMed ID: 16730037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.